The global sleeping aids market is expected to grow at a CAGR of 4.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing awareness about sleep disorders and their impact on health, growing geriatric population, and rising prevalence of lifestyle diseases.
The global sleeping aids market is segmented into medication, mattresses and pillows, sleep apnea devices, insomnia application segment (insomnia), restless legs syndrome application segment (restless legs syndrome), sleep apnea application segment (sleep apnea), narcolepsy application segment (narcolepsy) and sleep walking application segment (sleep walking). The medication type accounted for the largest share in the global sleeping aids market in 2018. This can be attributed to the fact that it is easy to use and available over-the-counter without any prescription or medical consultation required.
- The global sleeping aids market is expected to reach USD 8,890 million by 2022.
- Increasing prevalence of sleep disorders such as insomnia and sleep apnea are the major factors driving the growth of the global sleeping aids market.
- Increasing awareness about the benefits of natural remedies for sleep disorders is also driving the growth of this market.
- Lack of awareness about side effects associated with prescription drugs and high cost are restraining factors for this market.
Industry Growth Insights published a new data on “Sleeping Aids Market”. The research report is titled “Sleeping Aids Market research by Types (Medication, Mattresses and Pillows, Sleep Apnea Devices, Other), By Applications (Insomnia, Restless Legs Syndrome, Sleep Apnea, Narcolepsy, Sleep Walking, Other), By Players/Companies GlaxoSmithKline, Pfizer, Merck, Becton Dickinson, Hill-Rom, Koninklijke Philips, Teva Pharmaceuticals, Abecca Healthcare, Betterlifehealthcare, Cadwell Laboratories, Compumedics, Lifeline Corporation, Medical Depot, Natus Medical, Talley Group”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Sleeping Aids Market Research Report
By Type
Medication, Mattresses and Pillows, Sleep Apnea Devices, Other
By Application
Insomnia, Restless Legs Syndrome, Sleep Apnea, Narcolepsy, Sleep Walking, Other
By Companies
GlaxoSmithKline, Pfizer, Merck, Becton Dickinson, Hill-Rom, Koninklijke Philips, Teva Pharmaceuticals, Abecca Healthcare, Betterlifehealthcare, Cadwell Laboratories, Compumedics, Lifeline Corporation, Medical Depot, Natus Medical, Talley Group
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
247
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Sleeping Aids Market Report Segments:
The global Sleeping Aids market is segmented on the basis of:
Types
Medication, Mattresses and Pillows, Sleep Apnea Devices, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Insomnia, Restless Legs Syndrome, Sleep Apnea, Narcolepsy, Sleep Walking, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GlaxoSmithKline
- Pfizer
- Merck
- Becton Dickinson
- Hill-Rom
- Koninklijke Philips
- Teva Pharmaceuticals
- Abecca Healthcare
- Betterlifehealthcare
- Cadwell Laboratories
- Compumedics
- Lifeline Corporation
- Medical Depot
- Natus Medical
- Talley Group
Highlights of The Sleeping Aids Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Medication
- Mattresses and Pillows
- Sleep Apnea Devices
- Other
- By Application:
- Insomnia
- Restless Legs Syndrome
- Sleep Apnea
- Narcolepsy
- Sleep Walking
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Sleeping Aids Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Sleeping aids are medications or devices that help people sleep. Sleeping aids can be prescription medications, over-the-counter drugs, or devices.
Some of the key players operating in the sleeping aids market are GlaxoSmithKline, Pfizer, Merck, Becton Dickinson, Hill-Rom, Koninklijke Philips, Teva Pharmaceuticals, Abecca Healthcare, Betterlifehealthcare, Cadwell Laboratories, Compumedics, Lifeline Corporation, Medical Depot, Natus Medical, Talley Group.
The sleeping aids market is expected to grow at a compound annual growth rate of 4.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Sleeping Aids Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Sleeping Aids Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Sleeping Aids Market - Supply Chain
4.5. Global Sleeping Aids Market Forecast
4.5.1. Sleeping Aids Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Sleeping Aids Market Size (000 Units) and Y-o-Y Growth
4.5.3. Sleeping Aids Market Absolute $ Opportunity
5. Global Sleeping Aids Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Sleeping Aids Market Size and Volume Forecast by Type
5.3.1. Medication
5.3.2. Mattresses and Pillows
5.3.3. Sleep Apnea Devices
5.3.4. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Sleeping Aids Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Sleeping Aids Market Size and Volume Forecast by Application
6.3.1. Insomnia
6.3.2. Restless Legs Syndrome
6.3.3. Sleep Apnea
6.3.4. Narcolepsy
6.3.5. Sleep Walking
6.3.6. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Sleeping Aids Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Sleeping Aids Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Sleeping Aids Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Sleeping Aids Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Sleeping Aids Demand Share Forecast, 2019-2026
9. North America Sleeping Aids Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Sleeping Aids Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Sleeping Aids Market Size and Volume Forecast by Application
9.4.1. Insomnia
9.4.2. Restless Legs Syndrome
9.4.3. Sleep Apnea
9.4.4. Narcolepsy
9.4.5. Sleep Walking
9.4.6. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Sleeping Aids Market Size and Volume Forecast by Type
9.7.1. Medication
9.7.2. Mattresses and Pillows
9.7.3. Sleep Apnea Devices
9.7.4. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Sleeping Aids Demand Share Forecast, 2019-2026
10. Latin America Sleeping Aids Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Sleeping Aids Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Sleeping Aids Market Size and Volume Forecast by Application
10.4.1. Insomnia
10.4.2. Restless Legs Syndrome
10.4.3. Sleep Apnea
10.4.4. Narcolepsy
10.4.5. Sleep Walking
10.4.6. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Sleeping Aids Market Size and Volume Forecast by Type
10.7.1. Medication
10.7.2. Mattresses and Pillows
10.7.3. Sleep Apnea Devices
10.7.4. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Sleeping Aids Demand Share Forecast, 2019-2026
11. Europe Sleeping Aids Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Sleeping Aids Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Sleeping Aids Market Size and Volume Forecast by Application
11.4.1. Insomnia
11.4.2. Restless Legs Syndrome
11.4.3. Sleep Apnea
11.4.4. Narcolepsy
11.4.5. Sleep Walking
11.4.6. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Sleeping Aids Market Size and Volume Forecast by Type
11.7.1. Medication
11.7.2. Mattresses and Pillows
11.7.3. Sleep Apnea Devices
11.7.4. Other
11.8. Basis Point Share (BPS) Analysis by Type 11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Sleeping Aids Demand Share, 2019-2026
12. Asia Pacific Sleeping Aids Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Sleeping Aids Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Sleeping Aids Market Size and Volume Forecast by Application
12.4.1. Insomnia
12.4.2. Restless Legs Syndrome
12.4.3. Sleep Apnea
12.4.4. Narcolepsy
12.4.5. Sleep Walking
12.4.6. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Sleeping Aids Market Size and Volume Forecast by Type
12.7.1. Medication
12.7.2. Mattresses and Pillows
12.7.3. Sleep Apnea Devices
12.7.4. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Sleeping Aids Demand Share, 2019-2026
13. Middle East & Africa Sleeping Aids Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Sleeping Aids Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Sleeping Aids Market Size and Volume Forecast by Application
13.4.1. Insomnia
13.4.2. Restless Legs Syndrome
13.4.3. Sleep Apnea
13.4.4. Narcolepsy
13.4.5. Sleep Walking
13.4.6. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Sleeping Aids Market Size and Volume Forecast by Type
13.7.1. Medication
13.7.2. Mattresses and Pillows
13.7.3. Sleep Apnea Devices
13.7.4. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Sleeping Aids Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Sleeping Aids Market: Market Share Analysis
14.2. Sleeping Aids Distributors and Customers
14.3. Sleeping Aids Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. GlaxoSmithKline
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Pfizer
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Merck
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Becton Dickinson
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Hill-Rom
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Koninklijke Philips
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Teva Pharmaceuticals
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Abecca Healthcare
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Betterlifehealthcare
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Cadwell Laboratories
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Compumedics
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Lifeline Corporation
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Medical Depot
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Natus Medical
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Talley Group
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
